Skip to main content

Expensify Inc

For the period ended Sep 30, 2024. Filed Nov 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 8, 2024

EXFY$1.85-9.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

As of September 30,As of December 31,
20242023
Assets
Cash and cash equivalents$39,172$47,510
Accounts receivable, net12,65013,834
Settlement assets, net53,39139,261
Prepaid expenses9,0025,649
Other current assets24,32130,978
Total current assets138,536137,232
Capitalized software, net16,85912,494
Property and equipment, net13,76314,372
Lease right-of-use assets5,6116,435
Deferred tax assets, net489457
Other assets9885,794
Total assets$176,246$176,784
Liabilities and stockholders' equity
Accounts payable$1,035$1,425
Accrued expenses and other liabilities7,2949,390
Borrowings under line of credit—15,000
Current portion of long-term debt, net of original issue discount and debt issuance costs—7,655
Lease liabilities, current631432
Settlement liabilities39,37933,990
Total current liabilities48,33967,892
Lease liabilities, non-current5,9286,467
Other liabilities2,0451,681
Total liabilities56,31276,040
Commitments and contingencies (Note 4)
Stockholders' equity:
Preferred stock, par value $0.0001; 10,000,000 shares of preferred stock authorized as of September 30, 2024 and December 31, 2023; no shares of preferred stock issued and outstanding as of September 30, 2024 and December 31, 2023——
Common stock, par value $0.0001; 1,000,000,000 shares of Class A common stock authorized as of September 30, 2024 and December 31, 2023; 77,119,750 and 70,569,815 shares of Class A common stock issued and outstanding as of September 30, 2024 and December 31, 2023, respectively; 21,871,197 and 24,994,989 shares of LT10 common stock authorized as of September 30, 2024 and December 31, 2023, respectively; 4,209,827 and 7,333,619 shares of LT10 common stock issued and outstanding as of September 30, 2024 and December 31, 2023, respectively; 24,969,634 and 24,998,941 shares of LT50 common stock authorized as of September 30, 2024 and December 31, 2023, respectively; 7,597,099 and 7,321,894 shares of LT50 common stock issued and outstanding as of September 30, 2024 and December 31, 2023, respectively98
Additional paid-in capital269,441241,509
Accumulated deficit(149,516)(140,773)
Total stockholders' equity119,934100,744
Total liabilities and stockholders' equity$176,246$176,784

See accompanying notes to Condensed Consolidated Financial Statements.

2

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.